In February 1999, a workshop was held in Cortina, Italy to develop a consensus defining the
criteria for cure of acromegaly. The workshop was sponsored by the University of Brescia …

To study the currently available data of recurrence rates of functioning and nonfunctioning
pituitary adenomas following surgical cure and to analyze associated predisposing factors …

Abstract Purpose The 14th Acromegaly Consensus Conference was convened to consider
biochemical criteria for acromegaly diagnosis and evaluation of therapeutic efficacy …

Background Patients with acromegaly are treated with surgery, radiation therapy, and drugs
to reduce hypersecretion of growth hormone, but the treatments may be ineffective and have …

AACE= American Association of Clinical Endocrinologists; BEL=“best evidence” level;
BMD= bone mineral density; CPAP= continuous positive airway pressure; CPG= clinical …

Background Pegvisomant is a new growth hormone receptor antagonist that improves
symptoms and normalises insulin-like growth factor-1 (IGF-1) in a high proportion of patients …

Background and aim The aim of this study was to illustrate the present role of
transsphenoidal surgery as primary therapy in GH-secreting adenomas, and to compare the …

Context: Despite the growing application of endoscopic transsphenoidal surgery (ETSS),
outcomes for GH adenomas are not clearly defined. Objective: We reviewed our experience …

OBJECTIVE: The aim of this study was to report the results of a consecutive series of
patients undergoing pituitary surgery using a pure endoscopic endonasal approach and to …

✓ Initial attempts at transcranial approaches to the pituitary gland in the late 1800s and early
1900s resulted in a mortality rate that was generally considered prohibitive. Schloffer …